Video

Dr. Mohile on Using a Geriatric Assessment in Older Patients With Cancer

Supriya Gupta Mohile, MD, MS, professor of medicine and surgery, James Wilmot Cancer Institute, director, Geriatric Oncology Clinic, University of Rochester, discusses pooled findings with a geriatric assessment for older patients with cancer in an interview with OncLive during the 2018 ASCO Annual Meeting.

Supriya Gupta Mohile, MD, MS, professor of medicine and surgery, James Wilmot Cancer Institute, director, Geriatric Oncology Clinic, University of Rochester, discusses clustered findings with a geriatric assessment for older patients with cancer in an interview with OncLive during the 2018 ASCO Annual Meeting.

A geriatric assessment is a standardized tool to assess health status in older adults, using age, comorbidity, and performance status. However, those characteristics are not the most effective way to identify patients at highest risk of poor outcomes, Mohile explains. Evidence suggest that geriatric assessments can help oncologists identify patients who are at the highest risk of adverse outcomes, such as toxicity from treatment, hospitalization, mortality, and functional decline. These have also been published in recent ASCO guidelines, she adds.

Patients aged 70 and older may have medical conditions other than cancer that would make them unlikely candidates for clinical trials, but their life expectancy is often long enough to warrant cancer treatment; however, there are limited data for these patients. Mohile questions how oncologists can improve conversations about issues that older patients and caregivers care about, and how the geriatric assessment can be used to do that.

The clustered study showed that providing a geriatric assessment summary to oncologists increases the number and quality of discussions about age-related concerns and improves patient satisfaction.

<<< 2018 ASCO Annual Meeting

Related Videos
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Sheldon M. Feldman, MD
Rita Mukhtar, MD
Lajos Pusztai, MD, DPhil
Hope S. Rugo, MD
Karl Semaan, MD, MSc
Bradley McGregor, MD, discusses findings from a phase 1b study of abemaciclib  in clear cell renal cell carcinoma.